Proefskrifbespreking

Van Deventer, HT 1985. Die begronding van die Nederduitsch HervormdeKerk van Afrika se onderwysbeleid, 1902—1985: 'n Bydrae tot 'n opvoedingsteologieOngepubliseerde DD-proefskrif, Universiteit van Pretoria. Promotor:Prof TFJ Dreyer; Mede-Promotor: Prof CH Rautenbac

Marxisme 'n Trojaanse perd

Marxism a Trojan horseCommunism is not a direct danger at this moment in South Africa. Communism is fought against by the government. Terrorism is our daily enemy. Communism is forbidden by law. Albeit Marxism proceeds on a broad spectrum of South African life by the influence of certain academics, church leaders and politicians. The excuse is that Marxism is to be differentiated from Marxism-Leninism. The latter is supposed to be Communism. In this way Marxism eventually becomes the Trojan horse for Communism in the South African community

Boekbespreking

Landman, C & Whitelaw, DP (red) 1985 - Windows on origins / Oorspronge in oënskou: Opstelle oor die vroeë kerk ter ere van JAAA Stoop op sy sestigste verjaarsdagPretoria: Universiteit van Suid-Afrika. 102 bladsye. Prys R24 plus AVBBalke, W 1985 - Calvin und die Taufer: Evangelium oder religioser Humanismus. Ubersetzt von H Quistorp Minden - Westfalia Selbstverlag Pfr Dr HJJ Th Quistorp. 292 bladsye. Prys onbekend.Vorster, WS (red) 1985 - Views on violencePretoria: University of South Africa. 118 bladsye. Hardeband. Prys R13,00 plus AVB.Instituut vir Reformatoriese Studies, 1985 - Venster op die Onderwys. (Reeks nr S 3. Versamelwerke nr 24)Potchefstroom: PU vir CHO. 147 bladsye. Prys R7,00. 16 hoofstukke deur verskeie medewerkers

Short communication Increase in metal extractability after liming of sacrificial sewage sludge disposal soils

A sandy and a sandy clay-loam soil from two dedicated (sacrificial) sewage sludge disposal sites were incubated with a total lime equivalent of 45 Mg·ha-1. Both these soils were acidified (pH 4.0 to 4.2) and had a significant accumulation of organic material (organic C of 2.9 to 3.7 %) compared to non-polluted soils (organic C of 0.6 to 1.0 %). The limed soils did not attain the desired pH of 6.5 after 6 months\' incubation due to a high buffer capacity. After incubation, soil samples were taken from the incubated pots and the levels of Al, Fe, Mn, Cu, Zn, Pb and Cd were determined by atomic absorption spectrophotometry (AAS) after extraction with NH4-EDTA and BaCl2. Most of the metals extracted with BaCl2 (except Mn in the sandy soil and Cd in both soils) decreased after liming. The EDTA-extractable Mn, Fe, and Cd in both soils and Cu and Pb in the sandy clayloam soil increased after liming, whereas Al and Zn, decreased in extractability (Statistically significant differences could not be determined for the trial due to the trial not having been designed for the results that were obtained). Similar results were reported in the literature for EDTA metal extraction but the phenomenon was not elaborated upon, except for Cr. The increased extractability of some of the metals after liming could negatively influence the use of EDTA as an extracting agent in proposed heavy-metal guidelines for similar sacrificial soils. Should liming be considered as a strategy to decrease metal mobility in sacrificial soils, the observed increase in extractability becomes a cause for concern and should receive attention in further research. Water SA Vol. 31 (2) 2005: pp.271-27

Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: A randomised controlled trial

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Objective To evaluate if a pharmacist-led medication review is effective at reducing the anticholinergic/sedative load, as measured by the Drug Burden Index (DBI). Design Randomised controlled single blind trial. Setting 15 community pharmacies in the Northern Netherlands. Participants 157 community-dwelling patients aged ≥65 years who used ≥5 medicines for ≥3 months, including at least one psycholeptic/psychoanaleptic medication and who had a DBI≥1. Intervention A medication review by the community pharmacist in collaboration with the patient's general practitioner and patient. Primary and secondary outcomes measures The primary outcome was the proportion of patients whose DBI decreased by at least 0.5. Secondary outcomes were the presence of anticholinergic/sedative side effects, falls, cognitive function, activities of daily living, quality of life, hospital admission and mortality. Data were collected at baseline and 3 months follow-up. Results Mean participant age was 75.7 (SD, 6.9) years in the intervention arm and 76.6 (SD, 6.7) years in the control arm, the majority were female (respectively 69.3% and 72.0%). Logistic regression analysis showed no difference in the proportion of patients with a≥0.5 decrease in DBI between intervention arm (17.3%) and control arm (15.9%), (OR 1.04, CI 0.47 to 2.64, p=0.927). Intervention patients scored higher on the Digit Symbol Substitution Test, measure of cognitive function (OR 2.02, CI 1.11 to 3.67, p=0.021) and reported fewer sedative side effects (OR 0.61, CI 0.40 to 0.94, p=0.024) at follow-up. No significant difference was found for other secondary outcomes. Conclusions Pharmacist-led medication review as currently performed in the Netherlands was not effective in reducing the anticholinergic/sedative load, measured with the DBI, within the time frame of 3 months. Preventive strategies, signalling a rising load and taking action before chronic use of anticholinergic/sedative medication is established may be more successful. Trial registration number NCT02317666

Using pharmacy dispensing data to predict falls in older individuals

Aims Associations between individual medication use and falling in older individuals are well-documented. However, a comprehensive risk score that takes into account overall medication use and that can be used in daily pharmacy practice is lacking. We, therefore, aimed to determine whether pharmacy dispensing records can be used to predict falls. Methods A retrospective cohort study was conducted using pharmacy dispensing data and self-reported falls among 3454 Dutch individuals aged >= 65 years. Two different methods were used to classify medication exposure for each person: the drug burden index (DBI) for cumulative anticholinergic and sedative medication exposure as well as exposure to fall risk-increasing drugs (FRIDs). Multinomial regression analyses, adjusted for age and sex, were conducted to investigate the association between medication exposure and falling classified as nonfalling, single falling and recurrent falling. The predictive performances of the DBI and FRIDs exposure were estimated by the polytomous discrimination index (PDI). Results There were 521 single fallers (15%) and 485 recurrent fallers (14%). We found significant associations between a DBI >= 1 and single falling (adjusted odds ratio: 1.30 [95% confidence interval {CI}: 1.02-1.66]) and recurrent falling (adjusted odds ratio: 1.60 [95%CI: 1.25-2.04]). The PDI of the DBI model was 0.41 (95%CI: 0.39-0.42) and the PDI of the FRIDs model was 0.45 (95%CI: 0.43-0.47), indicating poor discrimination between fallers and nonfallers. Conclusion The study shows significant associations between medication use and falling. However, the medication-based models were insufficient and other factors should be included to develop a risk score for pharmacy practice

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3

Background: Assessment of DNA promoter methylation markers in cervical scrapings for the detection of cervical intraepithelial neoplasia (CIN) and cervical cancer is feasible, but finding methylation markers with both high sensitivity as well as high specificity remains a challenge. In this study, we aimed to identify new methylation markers for the detection of high-grade CIN (CIN2/3 or worse, CIN2+) by using innovative genome-wide methylation analysis (MethylCap-seq). We focused on diagnostic performance of methylation markers with high sensitivity and high specificity considering any methylation level as positive. Results: MethylCap-seq of normal cervices and CIN2/3 revealed 176 differentially methylated regions (DMRs) comprising 164 genes. After verification and validation of the 15 best discriminating genes with methylation-specific PCR (MSP), 9 genes showed significant differential methylation in an independent cohort of normal cervices versus CIN2/3 lesions (p < 0.05). For further diagnostic evaluation, these 9 markers were tested with quantitative MSP (QMSP) in cervical scrapings from 2 cohorts: (1) cervical carcinoma versus healthy controls and (2) patients referred from population-based screening with an abnormal Pap smear in whom also HPV status was determined. Methylation levels of 8/9 genes were significantly higher in carcinoma compared to normal scrapings. For all 8 genes, methylation levels increased with the severity of the underlying histological lesion in scrapings from patients referred with an abnormal Pap smear. In addition, the diagnostic performance was investigated, using these 8 new genes and 4 genes (previously identified by our group: C13ORF18, JAM3, EPB41L3, and TERT). In a triage setting (after a positive Pap smear), sensitivity for CIN2+ of the best combination of genes (C13ORF18/JAM3/ANKRD18CP) (74 %) was comparable to hrHPV testing (79 %), while specificity was significantly higher (76 % versus 42 %, p <= 0.05). In addition, in hrHPV-positive scrapings, sensitivity and specificity for CIN2+ of this best-performing combination was comparable to the population referred with abnormal Pap smear. Conclusions: We identified new CIN2/3-specific methylation markers using genome-wide DNA methylation analysis. The diagnostic performance of our new methylation panel shows higher specificity, which should result in prevention of unnecessary colposcopies for women referred with abnormal cytology. In addition, these newly found markers might be applied as a triage test in hrHPV-positive women from population-based screening. The next step before implementation in primary screening programs will be validation in population-based cohorts